LUMO · Lumos Pharma
Acquired Company
Double Point Ventures completed its acquisition of Lumos Pharma on December 12, 2024 via a tender offer of $4.25 per share in cash plus one CVR.
Pharmaceutical Preparation Manufacturing
Manufacturing
Market Cap
N/A
52 Wk Range
N/A - N/A
Previous Close
$4.34
Open
$4.34
Volume
N/A
Day Range
$4.34 - $4.34
Enterprise Value
N/A
Cash
N/A
Avg Qtr Burn
N/A
Insider Ownership
32.69%
Institutional Own.
24.27%
Qtr Updated
Sep 30th 2024